152 related articles for article (PubMed ID: 3049266)
1. Suppression of puerperal lactation by terguride. A double-blind study.
Venturini PL; Horowski R; Fasce V; Valenzano M; Ferreri C; Badino G; Rainer E; Scholz A; De Cecco L
Gynecol Obstet Invest; 1988; 26(1):33-8. PubMed ID: 3049266
[TBL] [Abstract][Full Text] [Related]
2. Effect of terguride on prolactin levels in normal, puerperal and hyperprolactinaemic women.
Venturini PL; Horowski R; Valenzano M; Costantini S; Fasce V; Gorlero F; Rainer E; De Cecco L
Eur J Clin Pharmacol; 1986; 30(2):195-7. PubMed ID: 3709645
[TBL] [Abstract][Full Text] [Related]
3. Suppression of lactation with lisuride.
Hardt W; Schmidt-Gollwitzer M; Horowski R
Gynecol Obstet Invest; 1979; 10(2-3):95-105. PubMed ID: 535777
[TBL] [Abstract][Full Text] [Related]
4. Effects of lisuride and bromocriptine on inhibition of lactation and on serum prolactin levels: comparative double-blind study.
Venturini PL; Horowski R; Maganza C; Morano S; Pedretti E; Ragni N; Semino F; De Cecco L
Eur J Obstet Gynecol Reprod Biol; 1981 May; 11(6):395-400. PubMed ID: 7018950
[TBL] [Abstract][Full Text] [Related]
5. Lactation-inhibiting and prolactin-lowering effect of lisuride and bromocriptine: a comparative study.
Van Dam LJ; Rolland R
Eur J Obstet Gynecol Reprod Biol; 1981 Nov; 12(5):323-30. PubMed ID: 7333409
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacologic arrest of lactation. Comparison of Deprenon, lisuride, terguride and mestranol].
Vido I; Cepický P
Cesk Gynekol; 1989 Nov; 54(9):654-61. PubMed ID: 2624954
[TBL] [Abstract][Full Text] [Related]
7. Effect of Lisuride on serum prolactin levels during puerperium.
Venturini PL; Maganza C; Massimilla A; Campanella P; Rossato P; Ragni N; De Cecco L
Acta Eur Fertil; 1979 Jun; 10(2):51-5. PubMed ID: 545976
[TBL] [Abstract][Full Text] [Related]
8. [Lactation inhibition with various dosages of lisuride--prolactin secretion and effectiveness].
Strahl HJ; Göretzlehner G; Strahl S; Kunkel S
Zentralbl Gynakol; 1985; 107(5):300-3. PubMed ID: 4039514
[TBL] [Abstract][Full Text] [Related]
9. Terguride--a new dopamine agonist drug: a comparison of its neuroendocrine and side effect profile with bromocriptine.
Ciccarelli E; Touzel R; Besser M; Grossman A
Fertil Steril; 1988 Apr; 49(4):589-94. PubMed ID: 3127243
[TBL] [Abstract][Full Text] [Related]
10. Endocrine and clinical results in administering lisuride for inhibiting lactation.
Zanagnolo VL; Pollini F; Falsetti L; Gastaldi A
Acta Eur Fertil; 1987; 18(1):21-4. PubMed ID: 3115024
[TBL] [Abstract][Full Text] [Related]
11. Lactation-inhibiting and prolactin-lowering effect of lisuride and transdihydrolisuride. A comparative study.
Vĕtr M; Konecný V
Acta Univ Palacki Olomuc Fac Med; 1988; 120():295-300. PubMed ID: 2977904
[No Abstract] [Full Text] [Related]
12. Effect of lisuride on inhibition of lactation and serum prolactin.
De Cecco L; Venturini PL; Ragni N; Rossato P; Maganza C; Gaggero G; Horowski R
Br J Obstet Gynaecol; 1979 Nov; 86(11):905-8. PubMed ID: 508675
[TBL] [Abstract][Full Text] [Related]
13. Effect of the new ergot derivative terguride on plasma PRL and GH levels in patients with pathological hyperprolactinemia or acromegaly.
Dallabonzana D; Liuzzi A; Oppizzi G; Verde G; Chiodini PG; Dorow R; Horowski R
J Endocrinol Invest; 1985 Apr; 8(2):147-51. PubMed ID: 4031381
[TBL] [Abstract][Full Text] [Related]
14. Prevention of puerperal lactation by a single oral administration of the new prolactin-inhibiting drug, cabergoline.
Melis GB; Mais V; Paoletti AM; Beneventi F; Gambacciani M; Fioretti P
Obstet Gynecol; 1988 Mar; 71(3 Pt 1):311-4. PubMed ID: 3279351
[TBL] [Abstract][Full Text] [Related]
15. Suppression of lactation with Terguride.
Vĕtr M; Krejcí I
Acta Univ Palacki Olomuc Fac Med; 1988; 119():347-52. PubMed ID: 2977495
[No Abstract] [Full Text] [Related]
16. Prolactin stimulation tests: different response patterns after bromocriptine, lisuride, and metergoline treatment of puerperal women.
Bohnet HG; Kato K; De Moll H
Obstet Gynecol; 1988 Jan; 71(1):53-5. PubMed ID: 3336541
[TBL] [Abstract][Full Text] [Related]
17. [The effect of several sexual steroids, 2-bromo-ergokryptin and lisurid-hydrogenmaleate an the postpartum concentration of serum prolactin and lactation (author's transl)].
Schmidt-Gollwitzer M; Hardt W; Schmidt-Gollwitzer K; Michel E; Nevinny-Stickel J
Geburtshilfe Frauenheilkd; 1977 Jun; 37(6):500-8. PubMed ID: 328335
[TBL] [Abstract][Full Text] [Related]
18. Oral cabergoline. Single-dose inhibition of puerperal lactation.
Caballero-Gordo A; Lopez-Nazareno N; Calderay M; Caballero JL; Mancheño E; Sghedoni D
J Reprod Med; 1991 Oct; 36(10):717-21. PubMed ID: 1683403
[TBL] [Abstract][Full Text] [Related]
19. [Terguride in hyperprolactinemia--experiences with 5 patients].
Wüster C; Scholz A; Schmelzle A; Horowski R; Ziegler R
Klin Wochenschr; 1990 Apr; 68(7):384-7. PubMed ID: 2188044
[TBL] [Abstract][Full Text] [Related]
20. Terguride as a new anti-hyperprolactinemic agent: characterization in rats and dogs in comparison with bromocriptine.
Mizokawa T; Akai T; Nakada Y; Yamaguchi M; Nakagawa H; Hasan S; Rettig KJ; Wachtel H
Jpn J Pharmacol; 1993 Nov; 63(3):269-78. PubMed ID: 7906316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
